IL-17 receptor and its functional significance in psoriatic arthritis
Identifieur interne : 001554 ( Main/Exploration ); précédent : 001553; suivant : 001555IL-17 receptor and its functional significance in psoriatic arthritis
Auteurs : Siba P. Raychaudhuri [États-Unis] ; Smriti K. Raychaudhuri [États-Unis] ; Mark C. Genovese [États-Unis]Source :
- Molecular and Cellular Biochemistry [ 0300-8177 ] ; 2012-01-01.
English descriptors
Abstract
Abstract: To delineate the functional significance of IL-17 Receptor (IL-17RA) and characterize the IL-17 producing T cell (Th17) subpopulation in psoriatic arthritis (PsA). Mononuclear cells from blood and synovial fluid (SF) were obtained from PsA (n = 20), rheumatoid arthritis (RA, n = 20) and osteoarthritis (OA, n = 20) patients. Synoviocytes (FLS) were isolated from the synovium of RA (n = 5), PsA (n = 5) and OA (n = 5) patients. IL-17RA expression in FLS was identified by western blotting (WB) and flowcytometry. T lymphocytes derived from the SF of these patients were studied to identify and phenotype the Th17 cells. The functional significance of IL-17RA was determined by evaluating its regulatory role on the production of proinflammatory cytokines and endopeptidase. IL-17RA expression was found to be significantly higher in FLS of RA (15.7% ± 4.9) and PsA (4.5% ± 0.9) in comparison to OA (1.14% ± 0.9). Western blot analyses showed that the relative intensity (RI) of IL-17RA protein was higher in RA and PsA compared to OA (Fisher exact, P < 0.01). A significant enrichment of IL-17-producing CD4+ T cells (7.9% ± 2.8) was observed in the SF of PsA patients compared to that of OA patients (P < .001). Compared to OA-FLS, recombinant IL-17 induced higher levels of IL-6, IL-8, and MMP-3 production in PsA-FLS. Blockage of IL-17RA with an anti-IL-17RA antibody inhibited the production of IL-6, IL-8, and MMP-3. This is the first report to demonstrate the functional significance of IL-17RA in PsA. Results of this study support the hypothesis that IL-17RA blocking antibodies have the potential to be a therapeutic option for psoriatic arthritis.
Url:
DOI: 10.1007/s11010-011-1036-6
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 002073
- to stream Istex, to step Curation: 002073
- to stream Istex, to step Checkpoint: 000530
- to stream Main, to step Merge: 001556
- to stream Main, to step Curation: 001554
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">IL-17 receptor and its functional significance in psoriatic arthritis</title><author><name sortKey="Raychaudhuri, Siba P" sort="Raychaudhuri, Siba P" uniqKey="Raychaudhuri S" first="Siba P." last="Raychaudhuri">Siba P. Raychaudhuri</name></author><author><name sortKey="Raychaudhuri, Smriti K" sort="Raychaudhuri, Smriti K" uniqKey="Raychaudhuri S" first="Smriti K." last="Raychaudhuri">Smriti K. Raychaudhuri</name></author><author><name sortKey="Genovese, Mark C" sort="Genovese, Mark C" uniqKey="Genovese M" first="Mark C." last="Genovese">Mark C. Genovese</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:6BAC082FF532939F6B49B1F8C94EF124C5B7A094</idno><date when="2011" year="2011">2011</date><idno type="doi">10.1007/s11010-011-1036-6</idno><idno type="url">https://api.istex.fr/ark:/67375/VQC-5JLV1TD5-L/fulltext.pdf</idno><idno type="wicri:Area/Istex/Corpus">002073</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">002073</idno><idno type="wicri:Area/Istex/Curation">002073</idno><idno type="wicri:Area/Istex/Checkpoint">000530</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000530</idno><idno type="wicri:doubleKey">0300-8177:2011:Raychaudhuri S:il:receptor:and</idno><idno type="wicri:Area/Main/Merge">001556</idno><idno type="wicri:Area/Main/Curation">001554</idno><idno type="wicri:Area/Main/Exploration">001554</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">IL-17 receptor and its functional significance in psoriatic arthritis</title><author><name sortKey="Raychaudhuri, Siba P" sort="Raychaudhuri, Siba P" uniqKey="Raychaudhuri S" first="Siba P." last="Raychaudhuri">Siba P. Raychaudhuri</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><wicri:regionArea>Division of Rheumatology, Allergy & Clinical Immunology, University of California Davis School of Medicine & VA Medical Center Sacramento, 1911 Geneva Place, 95618, Davis, CA</wicri:regionArea><placeName><region type="state">Californie</region></placeName></affiliation><affiliation wicri:level="1"><country wicri:rule="url">États-Unis</country></affiliation></author><author><name sortKey="Raychaudhuri, Smriti K" sort="Raychaudhuri, Smriti K" uniqKey="Raychaudhuri S" first="Smriti K." last="Raychaudhuri">Smriti K. Raychaudhuri</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><wicri:regionArea>Division of Rheumatology, Allergy & Clinical Immunology, University of California Davis School of Medicine & VA Medical Center Sacramento, 1911 Geneva Place, 95618, Davis, CA</wicri:regionArea><placeName><region type="state">Californie</region></placeName></affiliation></author><author><name sortKey="Genovese, Mark C" sort="Genovese, Mark C" uniqKey="Genovese M" first="Mark C." last="Genovese">Mark C. Genovese</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><wicri:regionArea>Stanford University School of Medicine, Immunology & Rheumatology, Stanford, CA</wicri:regionArea><placeName><region type="state">Californie</region></placeName></affiliation></author></analytic><monogr></monogr><series><title level="j">Molecular and Cellular Biochemistry</title><title level="j" type="sub">An International Journal for Chemical Biology in Health and Disease</title><title level="j" type="abbrev">Mol Cell Biochem</title><idno type="ISSN">0300-8177</idno><idno type="eISSN">1573-4919</idno><imprint><publisher>Springer US; http://www.springer-ny.com</publisher><pubPlace>Boston</pubPlace><date type="published" when="2012-01-01">2012-01-01</date><biblScope unit="volume">359</biblScope><biblScope unit="issue">1-2</biblScope><biblScope unit="page" from="419">419</biblScope><biblScope unit="page" to="429">429</biblScope></imprint><idno type="ISSN">0300-8177</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0300-8177</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>IL-17/IL-17R</term><term>Psoriasis</term><term>Psoriatic arthritis</term><term>Synovial tissue</term><term>Synoviocytes/FLS</term><term>Th17 cells</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Abstract: To delineate the functional significance of IL-17 Receptor (IL-17RA) and characterize the IL-17 producing T cell (Th17) subpopulation in psoriatic arthritis (PsA). Mononuclear cells from blood and synovial fluid (SF) were obtained from PsA (n = 20), rheumatoid arthritis (RA, n = 20) and osteoarthritis (OA, n = 20) patients. Synoviocytes (FLS) were isolated from the synovium of RA (n = 5), PsA (n = 5) and OA (n = 5) patients. IL-17RA expression in FLS was identified by western blotting (WB) and flowcytometry. T lymphocytes derived from the SF of these patients were studied to identify and phenotype the Th17 cells. The functional significance of IL-17RA was determined by evaluating its regulatory role on the production of proinflammatory cytokines and endopeptidase. IL-17RA expression was found to be significantly higher in FLS of RA (15.7% ± 4.9) and PsA (4.5% ± 0.9) in comparison to OA (1.14% ± 0.9). Western blot analyses showed that the relative intensity (RI) of IL-17RA protein was higher in RA and PsA compared to OA (Fisher exact, P < 0.01). A significant enrichment of IL-17-producing CD4+ T cells (7.9% ± 2.8) was observed in the SF of PsA patients compared to that of OA patients (P < .001). Compared to OA-FLS, recombinant IL-17 induced higher levels of IL-6, IL-8, and MMP-3 production in PsA-FLS. Blockage of IL-17RA with an anti-IL-17RA antibody inhibited the production of IL-6, IL-8, and MMP-3. This is the first report to demonstrate the functional significance of IL-17RA in PsA. Results of this study support the hypothesis that IL-17RA blocking antibodies have the potential to be a therapeutic option for psoriatic arthritis.</div></front></TEI><affiliations><list><country><li>États-Unis</li></country><region><li>Californie</li></region></list><tree><country name="États-Unis"><region name="Californie"><name sortKey="Raychaudhuri, Siba P" sort="Raychaudhuri, Siba P" uniqKey="Raychaudhuri S" first="Siba P." last="Raychaudhuri">Siba P. Raychaudhuri</name></region><name sortKey="Genovese, Mark C" sort="Genovese, Mark C" uniqKey="Genovese M" first="Mark C." last="Genovese">Mark C. Genovese</name><name sortKey="Raychaudhuri, Siba P" sort="Raychaudhuri, Siba P" uniqKey="Raychaudhuri S" first="Siba P." last="Raychaudhuri">Siba P. Raychaudhuri</name><name sortKey="Raychaudhuri, Smriti K" sort="Raychaudhuri, Smriti K" uniqKey="Raychaudhuri S" first="Smriti K." last="Raychaudhuri">Smriti K. Raychaudhuri</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001554 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001554 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= ChloroquineV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:6BAC082FF532939F6B49B1F8C94EF124C5B7A094
|texte= IL-17 receptor and its functional significance in psoriatic arthritis
}}
| This area was generated with Dilib version V0.6.33. |  |